BONE CANCER RESEARCH TRUST — grant history

Registered charity 1159590 · filings on the Charity Commission register · its own accounts analysis · funder finder · deadlines

Latest income

£4.2m

Grants listed (FY2023)

Listed grants total

£1.0m

Accounts grants total

£1.0m

listed grants reconcile with the accounts totalextracted from its FY2023 accounts

What this funder supports

Based on the register classifications and operating areas of the grant recipients we could match to the charity register (a subset of all grantees).

Causes funded

General Charitable Purposes (1 grantee)
Other Charitable Purposes (1 grantee)
The Advancement Of Health Or Saving Of Lives (1 grantee)

Where grantees operate

Northern Ireland (1 grantee)
Scotland (1 grantee)
Throughout England And Wales (1 grantee)

Grants made, per its accounts filings

Download this grant history as CSV (open data, provenance and licence noted in the file).

Recipient	Year	Amount	Purpose
Dr P Huang, Institute of Cancer Research, A deep dive into the proteomic landscape of chondrosarcoma: improving patient stratification and outcomes	FY2023	£250k	Research
Professor Alison Gartland, University of Sheffield, Understanding Chondrosarcoma from pathogenesis to new treatment options	FY2023	£162k	Research
Prof Sybille Mittnacht, UCL, Cancer Institute, PhD studentship	FY2023	£119k	Research
Prof Judith Bovee, Leiden University, Unravelling adamantinoma histogenesis	FY2023	£100k	Research
Prof S Strauss, UCL, Euro Ewing Consortium	FY2023	£99k	Research
Mr Kenneth Rankin, Newcastle, Optimisation of fluorescence technology for bone sarcoma image guided surgery and photodynamic therapy	FY2023	£77k	Research
Dr P Huang, Institute of Cancer Research, Evaluation of a gene expression-based risk classifier for tyrosine kinase inhibitor therapy in the INTER-EWING-1 and rEECur trials.	FY2023	£50k	Research
Stanmore infrastructure	FY2023	£42k	Research
Prof Sally Fletcher, University of Birmingham, Leveraging a new class of drug target to develop novel combination therapies for Chondrosarcoma	FY2023	£25k	Research
Dr M McCabe - Biological studies in rEECur, an international randomised controlled trial of chemotherapy for the treatment of recurrent and primary refractory Ewing sarcoma	FY2023	£23k	Research
Dr Katherine Trevers, UCL, Can cell-free RNA (cfRNA) be used to measure disease burden in chordoma	FY2023	£23k	Research
Dr Darrell Green, University of East Anglia, Single-cell profiling demonstrating childhood PBCintratumour heterogeneity: datasets for future reference	FY2023	£17k	Research
Skills development grants	FY2023	£15k	Research
Birmingham Orthopaedic Oncology Consensus Meeting (BOOM)	FY2023	£12k	Research
Prof Aykut Uren, Georgetown University, Lombardi Comprehensive Cancer Centre, Second Generation Clofarabine Derivatives as CD99 Inhibitors	FY2023	£3k	Research
Dr Abigail Evans, UCL, Meeting support EEC 2023	FY2023	£600	Research
Professor Sandra Strauss	FY2022	£998k	Ad-ICONIC Programme
Dr Lucia Cottone	FY2022	£500k	Cellular Dynamics Of Chemotherapy Resistance In Osteosarcoma Early Career Fellowship
Dr Paul Huang	FY2022	£250k	A deep dive into the proteomic landscape of chondrosarcoma: improving patient stratification and outcomes Large Project
Professor Alison Gartland	FY2022	£250k	Preclinical validation of novel compounds to treat osteosarcoma Large Project
Professor Robert Falconer	FY2022	£250k	Lead optimisation of a tumour-targeted methotrexate prodrug with enhanced therapeutic index for osteosarcoma Large Project
Dr Martin McCabe	FY2022	£188k	Biological studies in rEECur, an international randomised controlled trial of chemotherapy for the treatment of recurrent and primary refractory Ewing sarcoma Clinical Trial Support
Mr Gareth Stevens	FY2022	£54k	Sample Collection Support Grant - Birmingham (Y5) Infrastructure
Dr Hadley Sheppard	FY2022	£25k	Evaluating the therapeutic potential of senolytic agents in chordoma Idea
Professor Richard Martin	FY2022	£25k	Developing novel biomaterials for osteosarcoma and chordoma treatment Idea
Dr Katherine Trevers	FY2022	£23k	A proof of concept study: can cell-free RNA (cfRNA) be used to measure disease burden in chordoma? Ideas
Mr Kenneth Rankin	FY2022	£16k	Sample Collection Support Grant - Newcastle (Y5) Infrastructure
Dr Helen Knowles	FY2022	£10k	ANGPTL4 is a potential therapeutic target in osteosarcoma Idea
Dr Kogularamanan Suntharalingam	FY2022	£10k	Bone-seeking Metal-based Drugs to overcome Chemotherapy Resistant Osteosarcoma Subpopulations Idea
Mr Corey Chan	FY2022	£3k	Lab stay at Harvard Medical School Skills Development Grant
Dr Darrell Green	FY2022	£2k	TP53 Restoration using mRNA Vaccine Technology Idea
Dr Martin Pule	FY2022	£2k	Towards Engineered T Cells for Osteosarcoma PhD Studentship
Mr Fermin Pradies-Pinchete	FY2022	£1k	Lab stay at University of East Anglia Skills Development Grant
Miss Laura Regadera-Munoz	FY2022	£1k	Lab stay at University of East Anglia Skills Development Grant
Dr Stefan Zollner	FY2022	£723	Travel grant for Advances in Ewing Sarcoma meeting Skills Development Grant
Dr Maria Christina Manara	FY2022	£500	Travel grant for Advances in Ewing Sarcoma meeting Skills Development Grant
Dr Sara Sanchez Molina	FY2022	£500	Travel grant for Advances in Ewing Sarcoma meeting Skills Development Grant
Dr Joanna Kitlinska	FY2022	£500	Travel grant for Advances in Ewing Sarcoma meeting Skills Development Grant
Mr Maximilian Kerkoff	FY2022	£392	Travel grant for Advances in Ewing Sarcoma meeting Skills Development Grant
Mrs Sarah Vaughan	FY2022	£390	Travel grant for BSG attendance Skills Development Grant
Dr Antonio Romo Morales	FY2022	£235	Travel grant for Advances in Ewing Sarcoma meeting Skills Development Grant
Mr Tilman Hoelting	FY2022	£219	Travel grant for Advances in Ewing Sarcoma meeting Skills Development Grant
Ms Silvia Luchetta	FY2022	£200	Travel grant for Advances in Ewing Sarcoma meeting Skills Development Grant
Ms Sophie Richardson	FY2022	£57	Travel grant for Advances in Ewing Sarcoma meeting Skills Development Grant
Dr Olivier Pardo	FY2021	£250k	Modulation of interferon gamma-mediated signalling and immune response by fibroblast growth factor 2 in osteosarcoma
Professor Sibylle Mittnacht	FY2021	£249k	Developing genome-informed treatment to improve outcome in Osteosarcoma
Dr Sandra Strauss	FY2021	£175k	ICONIC: Improving outcome through Collaboration in OsteosarComa (Stage 2)
Professor Susan Burchill	FY2021	£150k	International collaboration to optimise the management of patients with Ewing sarcoma
Professor Gareth Veal	FY2021	£146k	Optimising the Treatment of Teenagers and Young Adults with Ewing Sarcoma through an Increased Understanding of Clinical Pharmacology and Toxicity Biomarkers
Professor Aykut Uren	FY2021	£70k	2nd Generation Clofarabine derivatives as CD99 inhibitors
Sarcoma UK	FY2021	£43k	Improving outcome in Sarcoma through Analysis and interrogation of National Cancer Data
University College London	FY2021	£36k	Euro Ewing Consortium
Dr Martin Pule	FY2021	£35k	Towards Engineered T Cells for Osteosarcoma (Year 1 Award)
Mr Jonathan Stevenson	FY2021	£30k	Sample Collection Support Grant - Birmingham (Y4)
Professor Adrienne Flanagan	FY2021	£28k	Sample Collection Support Grant - Stanmore (Y4)
Dr Darrell Green	FY2021	£20k	TP53 restoration using mRNA vaccine technology
Dr Kogularamanan Suntharalingam	FY2021	£20k	Bone-seeking metal-based drugs to overcome chemotherapy-resistant osteosarcoma subpopulations
Dr Karan Shah	FY2021	£20k	Delineating the role of hypoxic extracellular vesicles in pulmonary metastasis of osteosarcoma – a pilot study
Professor Alison Gartland	FY2021	£17k	The Role of Oestrogen in Chondrosarcoma Using Patient-Derived Xenograft Mouse Models: A Pilot study
Professor Robert Falconer	FY2021	£17k	Development of a targeted methotrexate prodrug with enhanced therapeutic index for osteosarcoma
Mr Kenneth Rankin	FY2021	£16k	Sample Collection Support Grant - Newcastle (Y4)

About this data

This grant list is extracted by automated reading of the grant-maker’s own accounts PDFs as filed with the Charity Commission, and cross-checked against the accounts’ stated grant totals (listed sum 1017683 vs reference 1017683 (0.0% diff; ref=stated)). Recipients are linked to register entries only on an exact charity-number or unambiguous exact-name match. If you represent this funder and want a correction, contact us.